Mobile

A multicenter open label study to compare efficacy and safety of induction treatment by ATG (thymoglobulin) versus anti-IL-2R (daclizumab) with a triple drug regimen (tacrolimus, mycophenolate mofetil...

Update Il y a 4 ans
Reference:

A multicenter open label study to compare efficacy and safety of induction treatment by ATG (thymoglobulin) versus anti-IL-2R (daclizumab) with a triple drug regimen (tacrolimus, mycophenolate mofetil, prednisone) in high risk renal transplant recipients

  • | Country :
  • France
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Inclusion criteria

  • Incidence of acute rejection in renal transplantation

Links